CrkL anticorps (pTyr207) (PE)

N° du produit ABIN1177226

Détail du produit anti-CrkL anticorps (PE)

Antigène: CrkL (CRKL) (V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL))

Épitope: pTyr207

Reactivité: Humain, Souris, Rat

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CrkL est conjugé à/à la PE

Application: Intracellular Staining (ICS)

Marque: BD Phosflow™

Purification: The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

Immunogène: Phosphorylated Human, Mouse, and Rat CrkL Peptide

Clone: K30-391-50-80

Isotype: IgG2a kappa

Information d'application

Indications d'application: This PE-conjugated antibody is suitable for intracellular staining of cell lines using BD Cytofix™ Fixation Buffer and BD Phosflow Perm Buffer III or IV. We have confirmed that the Alexa Fluor® 647 conjugate, Cat. No. 560790, is suitable for staining leukocytes from human peripheral blood and bone marrow.

Commentaires:

BALB/c

Volume d'échantillon: 20 μL

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Aqueous buffered solution containing BSA and ≤0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: The antibody was conjugated with R-PE under optimum conditions, and unconjugated antibody and free PE were removed. Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.

Références pour anticorps anti-CrkL (PE) (ABIN1177226)

Feller: "Crk family adaptors-signalling complex formation and biological roles." dans: Oncogene, Vol. 20, Issue 44, pp. 6348-71, (2001) (PubMed).

Arai, Nosaka, Kohsaka, Miyasaka, Miura: "CrkL activates integrin-mediated hematopoietic cell adhesion through the guanine nucleotide exchange factor C3G." dans: Blood, Vol. 93, Issue 11, pp. 3713-22, (1999) (PubMed).

Senechal, Heaney, Druker, Sawyers: "Structural requirements for function of the Crkl adapter protein in fibroblasts and hematopoietic cells." dans: Molecular and cellular biology, Vol. 18, Issue 9, pp. 5082-90, (1998) (PubMed).

Détails sur CrkL

Antigène: CrkL (CRKL) (V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL))

Autre désignation: CrkL (CRKL Produits)

Synonymes: anticorps CRKL, anticorps wu:fa55g05, anticorps wu:fj60e01, anticorps zgc:63469, anticorps 1110025F07Rik, anticorps AA589403, anticorps AI325100, anticorps Crkol, anticorps CRK like proto-oncogene, adaptor protein, anticorps v-crk avian sarcoma virus CT10 oncogene homolog-like, anticorps CRKL, anticorps crkl, anticorps Crkl

Sujet: Crk-Like (CrkL) is an adaptor protein that is preferentially expressed in hematopoietic cells and is encoded by a gene that is homologous to the viral oncogene v-crk (chicken tumor virus no. 10 regulator of kinase). Its SH2 and SH3 domains bind to a variety of effector proteins, such as paxillin, p130Cas, c-Cbl, c-Abl, and C3G. These interactions are involved in the regulation of cellular migration, adhesion, and transformation. Tyrosine 207 (Y207) of CrkL is phosphorylated in hematopoietic cells that express the BCR-ABL fusion protein. This site may be a negative regulator of protein complex formation and biological activity. The K30-391.50.80 monoclonal antibody recognizes the phosphorylated Y207 of human CrkL.

Pathways: Interferon-gamma Pathway, Neurotrophin Signaling Pathway, Signaling of Hepatocyte Growth Factor Receptor